Publication: A discrete choice experiment to derive health utilities for aromatic L-amino acid decarboxylase (AADC) deficiency in France
This research article, published in Patient Related Outcome Measures, provides results from a discrete choice experiment to determine health utility values for AADC deficiency, carried out using a sample of the general population in France
- Find out more about the methodology used to select a representative sample of the general French population for this study
- Review the health utilities for AADC deficiency syndromes derived from this analysis
- Understand more about the perceived impact of the different symptoms of AADC deficiency, and how this is affected by disease progression
Smith AB, Hanbury A, Whitty JA, et al. Patient Relat Outcome Meas. 2022;13:21–30
Thank you!
Already registered?
Register now to access the content on this page
Already registered?
If not, register below
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our Privacy Statement and our Terms and Conditions do not apply.
We encourage you to read the Privacy Policy and the Terms and Conditions of every website you visit. PTC Therapeutics does not endorse and/or influence the content found on websites not owned/operated by PTC Therapeutics.
MED-ALL-CORP-2200029 | June 2025
COMING SOON
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.